Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.

Aki Morikawa,Rui Wang,Sujata Patil,Adi Diab,Jonathan Yang,Clifford A Hudis,Heather L McArthur,Kathryn Beal,Andrew D Seidman

Clinical Breast Cancer（2018）

引用 16|浏览22

暂无评分

摘要

Our finding supports the continued use of HER2-targeted therapy after BM diagnosis. In addition, future research on the clinical impact of detecting asymptomatic BM in patients with HER2 BC, in terms of improving prognosis, quality of life, and avoidance of whole brain radiotherapy, is warranted.

查看译文

关键词

Breast cancer epidemiology,Central nervous system metastasis,HER2-positive,Metastatic breast cancer,Prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要